![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: John Wiley & Sons Inc
E-ISSN: 1099-1069|36|1|174-181
ISSN: 0278-0232
Source: Hematological Oncology (Electronic), Vol.36, Iss.1, 2018-02, pp. : 174-181
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
mTOR as a Target of Everolimus in Refractory/Relapsed Hodgkin Lymphoma
Current Medicinal Chemistry, Vol. 19, Iss. 7, 2012-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drugs in R&D, Vol. 11, Iss. 1, 2011-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)